Literature DB >> 23787161

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.

A Mailles1, K Blanckaert, P Chaud, S van der Werf, B Lina, V Caro, C Campese, B Guéry, H Prouvost, X Lemaire, M C Paty, S Haeghebaert, D Antoine, N Ettahar, H Noel, S Behillil, S Hendricx, J C Manuguerra, V Enouf, G La Ruche, Caroline Semaille, B Coignard, D Lévy-Bruhl, F Weber, C Saura, D Che.   

Abstract

In May 2013, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection was diagnosed in an adult male in France with severe respiratory illness, who had travelled to the United Arab Emirates before symptom onset. Contact tracing identified a secondary case in a patient hospitalised in the same hospital room. No other cases of MERS-CoV infection were identified among the index case’s 123 contacts, nor among 39 contacts of the secondary case, during the 10-day follow-up period.

Entities:  

Mesh:

Year:  2013        PMID: 23787161

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  80 in total

Review 1.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 2.  Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.

Authors:  Jasper F W Chan; Susanna K P Lau; Kelvin K W To; Vincent C C Cheng; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 3.  MERS coronavirus: diagnostics, epidemiology and transmission.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Virol J       Date:  2015-12-22       Impact factor: 4.099

4.  A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.

Authors:  Lanying Du; Guangyu Zhao; Yang Yang; Hongjie Qiu; Lili Wang; Zhihua Kou; Xinrong Tao; Hong Yu; Shihui Sun; Chien-Te K Tseng; Shibo Jiang; Fang Li; Yusen Zhou
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

Review 5.  Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.

Authors:  Heeyoun Cho; Jean-Louis Excler; Jerome H Kim; In-Kyu Yoon
Journal:  Hum Vaccin Immunother       Date:  2017-11-29       Impact factor: 3.452

6.  One-Pot Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) for Detecting MERS-CoV.

Authors:  Se Hee Lee; Yun Hee Baek; Yang-Hoon Kim; Young-Ki Choi; Min-Suk Song; Ji-Young Ahn
Journal:  Front Microbiol       Date:  2017-01-09       Impact factor: 5.640

7.  Tracing Airline Travelers for a Public Health Investigation: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, 2014.

Authors:  Joanna J Regan; M Robynne Jungerman; Susan A Lippold; Faith Washburn; Efrosini Roland; Tina Objio; Christopher Schembri; Reena Gulati; Paul J Edelson; Francisco Alvarado-Ramy; Nicki Pesik; Nicole J Cohen
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

8.  Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.

Authors:  Christopher M Coleman; Krystal L Matthews; Lindsay Goicochea; Matthew B Frieman
Journal:  J Gen Virol       Date:  2013-11-06       Impact factor: 3.891

9.  Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.

Authors:  Mohamad Hesam Shahrajabian; Wenli Sun; Qi Cheng
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

10.  New coronavirus outbreak. Lessons learned from the severe acute respiratory syndrome epidemic.

Authors:  E Álvarez; J Donado-Campos; F Morilla
Journal:  Epidemiol Infect       Date:  2015-01-16       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.